Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with chemoradiation in locally advanced rectal cancer
NCT00113230Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2005
- Primary completion
- Jan 2009
- Countries
- 1
01
Overview
Phase 2, open-label trial of bevacizumab in rectal cancer, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Pathologic Local Tumor Response at 5 months. Started Feb 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00113230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113230.